Axsome Therapeutics, Inc. (AXSM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1238138,
    "name": "Axsome Therapeutics, Inc.",
    "stock_name": "Axsome Therapeutics, Inc.",
    "full_name": "Axsome Therapeutics, Inc.",
    "name_url": "stocks-analysis/axsome-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "148.04",
    "chg": 5.95,
    "chgp": "4.19%",
    "dir": 1,
    "prev_price": "142.09",
    "mcapval": "6,451.76",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US05464T1043",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "717.35 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/axsome-therapeutics-inc-1238138-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Axsome Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-axsome-therapeutics-inc-technically-bullish-or-bearish-3546252",
        "imagepath": "",
        "date": "2025-09-20 19:27:55",
        "description": "As of 18 August 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and the moving averages are bullish on the daily. Bollinger Bands show a bullish signal on the weekly and a mildly bullish signal on the monthly. The KST is bullish for both weekly and monthly periods. However, Dow Theory indicates a mildly bearish stance on the weekly while being mildly bullish on the monthly, and the OBV shows a mildly bearish signal on the weekly but mildly bullish on the monthly.\n\nIn terms of performance, Axsome Therapeutics has outperformed the S&P 500 over the year with a return of 29.59% compared to the S&P 500's 17.14%, and significantly over the YTD with a return of 40.21% against the S&P 500's 12.22%...."
      },
      {
        "title": "Is Axsome Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-axsome-therapeutics-inc-overvalued-or-undervalued-3542851",
        "imagepath": "",
        "date": "2025-09-20 18:03:50",
        "description": "As of 9 August 2022, the valuation grade for Axsome Therapeutics, Inc. moved from does not qualify to risky, indicating increased caution regarding its investment potential. The company appears overvalued, particularly given its high price-to-book value of 103.56 and negative earnings metrics, such as an EV to EBITDA ratio of -23.34 and an ROE of -464.66%. In comparison, BioMarin Pharmaceutical, Inc. has a fair valuation with a P/E of 15.17, while BridgeBio Pharma, Inc. is also classified as risky with a P/E of -14.12.\n\nDespite a strong year-to-date return of 40.21% compared to the S&P 500's 12.22%, the overall financial metrics suggest that Axsome Therapeutics is not a sound investment at its current valuation levels...."
      }
    ],
    "total": 7,
    "sid": "1238138",
    "stock_news_url": "https://www.marketsmojo.com/news/axsome-therapeutics-inc-1238138"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Axsome Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:27:55

As of 18 August 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and the moving averages are bullish on the daily. Bollinger Bands show a bullish signal on the weekly and a mildly bullish signal on the monthly. The KST is bullish for both weekly and monthly periods. However, Dow Theory indicates a mildly bearish stance on the weekly while being mildly bullish on the monthly, and the OBV shows a mildly bearish signal on the weekly but mildly bullish on the monthly. In terms of performance, Axsome Therapeutics has outperformed the S&P 500 over the year with a return of 29.59% compared to the S&P 500's 17.14%, and significantly over the YTD with a return of 40.21% against the S&P 500's 12.22%....

Is Axsome Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:03:50

As of 9 August 2022, the valuation grade for Axsome Therapeutics, Inc. moved from does not qualify to risky, indicating increased caution regarding its investment potential. The company appears overvalued, particularly given its high price-to-book value of 103.56 and negative earnings metrics, such as an EV to EBITDA ratio of -23.34 and an ROE of -464.66%. In comparison, BioMarin Pharmaceutical, Inc. has a fair valuation with a P/E of 15.17, while BridgeBio Pharma, Inc. is also classified as risky with a P/E of -14.12. Despite a strong year-to-date return of 40.21% compared to the S&P 500's 12.22%, the overall financial metrics suggest that Axsome Therapeutics is not a sound investment at its current valuation levels....

View All News